I find that U.S. IPO prospectus disclosure exhibits significant correlation with first day underpricing, consistent with theories of underpricing as caused by informational asymmetry. In particular, a 1 standard deviation increase in positive prospectus disclosure is associated with almost a...

I examine the change in voluntary IPO disclosure of internal controls after the JOBS Act. The JOBS Act postponed the compliance deadline of internal control audits after IPO. Simultaneously, it increased the number of small IPO firms with potential control weaknesses. I find that IPO firms are...

This paper investigates the effect of mandatory disclosure requirements for private firms on their decision to go public. Using detailed project-level data for biopharmaceutical firms, we explore the effects of a legal reform---the Food and Drug Administration Amendments Act (FDAAA)---which...